Verizon’s Kyle Malady sells $50,721 in common stock By Investing.com
Verizon’s Kyle Malady sells $50,721 in common stock By Investing.com Investing.com UK
Covered in this story
Analyst targets on Verizon
- Citi: at $43.2 · target $53 by Oct 2027 via GuruFocus
- TD Cowen: at $43.8 · target $55 by Oct 2027 · Buy via GuruFocus
- Barclays: at $43.9 · target $44 by Oct 2027 via GuruFocus
“At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target. Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $VZ yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Verizon →Dalsna Finance is currently tracking 40 stories mentioning Verizon, the earliest published 7 Apr 2026.
Summary aggregated from Investing.com UK's public RSS feed. The full reporting belongs to Investing.com UK — please read it on their site.